PCAT7 and breast carcinoma: Ghaemi Z found that miR-326 can inhibit the occurrence of breast cancer by regulating the ERBB/PI3K pathway [39], and in addition, lncRNA PCAT7 can activate the ERBB/PI3K/AKT pathway to promote breast cancer progression [40].